205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.56%
Net income growth above 1.5x ADI's 3.69%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-2.81%
Negative yoy D&A while ADI is 0.71%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-345.83%
Negative yoy deferred tax while ADI stands at 106.98%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
5.56%
SBC growth well above ADI's 2.24%. Michael Burry would flag major dilution risk vs. competitor’s approach.
101.29%
Less working capital growth vs. ADI's 1250.39%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
24.00%
AR growth of 24.00% while ADI is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
37.72%
Inventory growth of 37.72% while ADI is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
137.50%
AP growth of 137.50% while ADI is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
177.03%
Lower 'other working capital' growth vs. ADI's 1250.39%. David Dodd would see fewer unexpected short-term demands on cash.
-60.32%
Both negative yoy, with ADI at -188.98%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
63.71%
Operating cash flow growth 1.25-1.5x ADI's 45.74%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-27.42%
Both yoy lines negative, with ADI at -10.33%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-396.50%
Both yoy lines negative, with ADI at -18.86%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
34.44%
Proceeds from sales/maturities above 1.5x ADI's 11.49%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-4966.67%
We reduce yoy other investing while ADI is 59.08%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-88.66%
Both yoy lines negative, with ADI at -68.92%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
183.82%
Issuance growth of 183.82% while ADI is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
16.35%
We have some buyback growth while ADI is negative at -61.88%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.